Patent Deals Accelerate Access To Generics, Drug Group Says

By Adam Lidgett · June 3, 2025, 8:55 PM EDT

Deals between the makers of brand name drugs and the companies behind their generic versions have led to billions of dollars in healthcare cost savings and faster access to cheaper medicines,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Analysis

Recent Articles By Adam

April 11, 2025
Foreign Cos. Say Anti-Choking Device Patent Is Invalid
April 11, 2025
Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement
April 08, 2025
Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
April 07, 2025
Incyte Can't Get Pretrial Win In Novartis Royalty Fight
April 03, 2025
Texas Appeals Court Backs UT Royalty Award In Pet Co. Suit
March 27, 2025
Fitch Even Sues Ex-IP Client In Effort To End Malpractice Case
March 24, 2025
Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out
March 18, 2025
Bausch Eye Vitamin Case Should Go To Jury, Judge Says
March 18, 2025
AI Healthcare Co. Accuses Test-Maker Of Infringing Patents
January 22, 2025
Vanda Loses Takings Clause Arguments In Trade Secret Fight